The distal hereditary motor neuropathies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 1, 2012, Pages 6-14

  Rossor, Alexander M ^a   Kalmar, Bernadett ^a   Greensmith, Linda ^a   Reilly, Mary M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; DEAD BOX PROTEIN 20; DYNEIN ADENOSINE TRIPHOSPHATASE; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; VANILLOID RECEPTOR 4;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ATP7A GENE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BERARDINELLI SEIP CONGENITAL LIPODYSTROPHY TYPE 2 GENE; CONGENITAL GENERALIZED LIPODYSTROPHY; DISEASE CLASSIFICATION; DISTAL HEREDITARY MOTOR NEUROPATHY; DYNACTIN 1 GENE; DYNEIN HEAVY CHAIN 1 GENE; ELECTROMYOGRAM; GENE; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; GLYCYL TRNA SYNTHETASE GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY SPINAL MUSCULAR ATROPHY; HSP8 GENE; HSPB1 GENE; HSPB3 GENE; HUMAN; IMMUNOGLOBULIN MU BINDING PROTEIN 2 GENE; MENKES SYNDROME; MOTOR NEUROPATHY; NEUROFILAMENT; NONHUMAN; PLECKSTRIN HOMOLOGY DOMAIN CONTAINING FAMILY G MEMBER 5 GENE; PRIORITY JOURNAL; REVIEW; SENATAXIN GENE; SILVER RUSSELL SYNDROME; SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS TYPE 1; TRANSIENT RECEPTOR VALLANOID 4 GENE; UNFOLDED PROTEIN RESPONSE;

ADENOSINE TRIPHOSPHATASES; CATION TRANSPORT PROTEINS; DNA-BINDING PROTEINS; GLYCINE-TRNA LIGASE; GTP-BINDING PROTEIN GAMMA SUBUNITS; HEAT-SHOCK PROTEINS; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA HELICASES; TRANSCRIPTION FACTORS; TRPV CATION CHANNELS;

EID: 84055207492     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300952     Document Type: Review

References (136)

1. Udd B. Molecular biology of distal muscular dystrophies - sarcomeric proteins on top. Biochim Biophys Acta 2007;1772:145-58.
2. Dierick I, Baets J, Irobi J, et al. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain 2008;131:1217-27.
3. Harding AE. Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. In: Dyck PJ, Thomas PK, Griffin JW, et al., eds. Peripheral Neuropathy. Philadelphia: W. B. Saunders Company, 1993:1051-64.
4. Irobi J, Dierick I, Jordanova A, et al. Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Med 2006;8:131-46.
5. De Jonghe P, Auer-Grumbach M, Irobi J, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain 2002;125:1320-5. (Pubitemid 34587141)
6. Zimon M, Baets J, Auer-Grumbach M, et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 2010;133:1798-809.
7. Christodoulou K, Zamba E, Tsingis M, et al. A novel form of distal hereditary motor neuronopathy maps to chromosome 9p21.1-p12. Ann Neurol 2000;48:877-84.
8. Gopinath S, Blair IP, Kennerson ML, et al. A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36. Hum Genet 2007;121:559-64. (Pubitemid 46706067)
9. Muglia M, Magariello A, Citrigno L, et al. A novel locus for dHMN with pyramidal features maps to chromosome 4q34.3-q35.2. Clin Genet 2008;73:486-91. (Pubitemid 351517264)
10. Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003;72:1293-9. (Pubitemid 36530017)
11. Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004;36:271-6. (Pubitemid 38282752)
12. Dick KJ, McEntagart M, Alwan W, et al. Refinement of the locus for distal hereditary motor neuronopathy VII (dHMN-VII) and exclusion of candidate genes. Genome 2008;51:959-62.
13. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455-6. (Pubitemid 36390002)
14. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004;36:602-6. (Pubitemid 38715987)
15. Ismailov SM, Fedotov VP, Dadali EL, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet 2001;9:646-50. (Pubitemid 32776383)
16. Chung KW, Kim SB, Cho SY, et al. Distal hereditary motor neuropathy in Korean patients with a small heat shock protein 27 mutation. Exp Mol Med 2008;40:304-12.
17. Houlden H, Laura M, Wavrant-De Vrieze F, et al. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology 2008;71:1660-8.
18. Ikeda Y, Abe A, Ishida C, et al. A clinical phenotype of distal hereditary motor neuronopathy type II with a novel HSPB1 mutation. J Neurol Sci 2009;277:9-12.
19. James PA, Rankin J, Talbot K. Asymmetrical late onset motor neuropathy associated with a novel mutation in the small heat shock protein HSPB1 (HSP27). J Neurol Neurosurg Psychiatry 2008;79:461-3. (Pubitemid 351441509)
20. Kijima K, Numakura C, Goto T, et al. Small heat shock protein 27 mutation in a Japanese patient with distal hereditary motor neuropathy. J Hum Genet 2005;50:473-6. (Pubitemid 41483334)
21. Luigetti M, Fabrizi GM, Madia F, et al. A novel HSPB1 mutation in an Italian patient with CMT2/dHMN phenotype. J Neurol Sci 2010;298:114-17.
22. Mandich P, Grandis M, Varese A, et al. Severe neuropathy after diphtheria-tetanus-pertussis vaccination in a child carrying a novel frame-shift mutation in the small heat-shock protein 27 gene. J Child Neurol 2010;25:107-9.
23. Solla P, Vannelli A, Bolino A, et al. Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 2010;81:958-62.
24. Benedetti S, Previtali SC, Coviello S, et al. Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis. Arch Neurol 2010;67:1498-505.
25. Zhai J, Lin H, Julien JP, et al. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Hum Mol Genet 2007;16:3103-16. (Pubitemid 350131329)
26. Ackerley S, James PA, Kalli A, et al. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet 2006;15:347-54. (Pubitemid 43125988)
27. d'Ydewalle C, Krishnan J, Chiheb DM, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med 2011;17:968-74.
28. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004;36:597-601. (Pubitemid 38715986)
29. Tang BS, Zhao GH, Luo W, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 2005;116:222-4. (Pubitemid 40174008)
30. Shemetov AA, Seit-Nebi AS, Gusev NB. Structure, properties, and functions of the human small heat-shock protein HSP22 (HspB8, H11, E2IG1): a critical review. J Neurosci Res 2008;86:264-9. (Pubitemid 351196732)
31. Tang BS, Luo W, Xia K, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet 2004;114:527-33. (Pubitemid 39010849)
32. Kappe G, Franck E, Verschuure P, et al. The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 2003;8:53-61. (Pubitemid 36444090)
33. Benn SC, Perrelet D, Kato AC, et al. Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 2002;36:45-56.
34. Fontaine JM, Sun X, Hoppe AD, et al. Abnormal small heat shock protein interactions involving neuropathy-associated HSP22 (HSPB8) mutants. FASEB J 2006;20:2168-70.
35. Irobi J, Almeida-Souza L, Asselbergh B, et al. Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet 2010;19:3254-65.
36. Carra S, Sivilotti M, Chavez Zobel AT, et al. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet 2005;14:1659-69. (Pubitemid 40895518)
37. Crippa V, Sau D, Rusmini P, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 2010;19:3440-56.
38. Carra S, Boncoraglio A, Kanon B, et al. Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases. J Biol Chem 2010;285:37811-22.
39. Arndt V, Dick N, Tawo R, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010;20:143-8.
40. Selcen D, Muntoni F, Burton BK, et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009;65:83-9.
41. Sun X, Fontaine JM, Hoppe AD, et al. Abnormal interaction of motor neuropathy-associated mutant HspB8 (Hsp22) forms with the RNA helicase Ddx20 (gemin3). Cell Stress Chaperones 2010;15:567-82.
42. Boelens WC, Van Boekel MA, De Jong WW. HspB3, the most deviating of the six known human small heat shock proteins. Biochim Biophys Acta 1998;1388:513-16. (Pubitemid 28526613)
43. Kolb SJ, Snyder PJ, Poi EJ, et al. Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology 2010;74:502-6.
44. Ibba M, Soll D. Aminoacyl-tRNAs: setting the limits of the genetic code. Genes Dev 2004;18:731-8. (Pubitemid 38480885)
45. Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006;38:197-202. (Pubitemid 43177233)
46. Latour P, Thauvin-Robinet C, Baudelet-Mery C, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2010;86:77-82.
47. McLaughlin HM, Sakaguchi R, Liu C, et al. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 2010;87:560-6.
48. Abe A, Hayasaka K. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy. J Hum Genet 2009;54:310-12.
49. Del Bo R, Locatelli F, Corti S, et al. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 2006;66:752-4. (Pubitemid 43739837)
50. James PA, Cader MZ, Muntoni F, et al. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology 2006;67:1710-12. (Pubitemid 44747957)
51. Rohkamm B, Reilly MM, Lochmuller H, et al. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci 2007;263:100-6. (Pubitemid 350029846)
52. Sivakumar K, Kyriakides T, Puls I, et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005;128:2304-14. (Pubitemid 41407971)
53. Dubourg O, Azzedine H, Yaou RB, et al. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. Neurology 2006;66:1721-6. (Pubitemid 43964629)
54. Motley WW, Talbot K, Fischbeck KH. GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci 2010;33:59-66.
55. Nangle LA, Zhang W, Xie W, et al. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci U S A 2007;104:11239-44. (Pubitemid 47175125)
56. Xie W, Nangle LA, Zhang W, et al. Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc Natl Acad Sci U S A 2007;104:9976-81. (Pubitemid 47175248)
57. Seburn KL, Nangle LA, Cox GA, et al. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 2006;51:715-26. (Pubitemid 44374911)
58. Antonellis A, Lee-Lin SQ, Wasterlain A, et al. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J Neurosci 2006;26:10397-406. (Pubitemid 44564590)
59. Achilli F, Bros-Facer V, Williams HP, et al. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech 2009;2:359-73.
60. Park SG, Kim HJ, Min YH, et al. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci U S A 2005;102:6356-61.
61. Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 2003;88:4840-7. (Pubitemid 37357534)
62. Auer-Grumbach M, Loscher WN, Wagner K, et al. Phenotypic and genotypic heterogeneity in hereditary motor neuronopathy type V: a clinical, electrophysiological and genetic study. Brain 2000;123:1612-23. (Pubitemid 30481185)
63. Windpassinger C, Wagner K, Petek E, et al. Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes. Hum Genet 2003;114:99-109. (Pubitemid 38165540)
64. Silver JR. Familial spastic paraplegia with amyotrophy of the hands. Ann Hum Genet 1966;30:69-75.
65. Auer-Grumbach M, Schlotter-Weigel B, Lochmuller H, et al. Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. Ann Neurol 2005;57:415-24. (Pubitemid 40343964)
66. Brusse E, Majoor-Krakauer D, de Graaf BM, et al. A novel 16p locus associated with BSCL2 hereditary motor neuronopathy: a genetic modifier? Neurogenetics 2009;10:289-97.
67. Cafforio G, Calabrese R, Morelli N, et al. The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation. Neurol Sci 2008;29:189-91. (Pubitemid 352003658)
68. Chen B, Zheng R, Luan X, et al. Clincial and pathological study of distal motor neuropathy with N88S mutation in BSCL2. Neuropathology 2009;29:543-7.
69. Cho HJ, Sung DH, Ki CS. Identification of de novo BSCL2 Ser90Leu mutation in a Korean family with Silver syndrome and distal hereditary motor neuropathy. Muscle Nerve 2007;36:384-6.
70. Irobi J, Van den Bergh P, Merlini L, et al. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 2004;127:2124-30. (Pubitemid 39150269)
71. Luigetti M, Fabrizi GM, Madia F, et al. Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. Muscle Nerve 2010;42:448-51.
72. Rakocevic-Stojanovic V, Milic-Rasic V, Peric S, et al. N88S mutation in the BSCL2 gene in a Serbian family with distal hereditary motor neuropathy type V or Silver syndrome. J Neurol Sci 2010;296:107-9.
73. Ito D, Suzuki N. Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain 2009;132:8-15.
74. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999;13:1211-33. (Pubitemid 29250189)
75. Liu CY, Kaufman RJ. The unfolded protein response. J Cell Sci 2003;116:1861-2. (Pubitemid 36622284)
76. Ito D, Fujisawa T, Iida H, et al. Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17. Neurobiol Dis 2008;31:266-77.
77. Yagi T, Ito D, Nihei Y, et al. N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress. Hum Mol Genet 2011;20:3831-40.
78. Pitt M, Houlden H, Jacobs J, et al. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain 2003;126:2682-92. (Pubitemid 37463087)
79. Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998;21:1327-37. (Pubitemid 29022535)
80. Joseph S, Robb SA, Mohammed S, et al. Interfamilial phenotypic heterogeneity in SMARD1. Neuromuscul Disord 2009;19:193-5.
81. Pierson TM, Tart G, Adams D, et al. Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man. Neuromuscul Disord 2011;21:353-5.
82. Guenther UP, Handoko L, Laggerbauer B, et al. IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Hum Mol Genet 2009;18:1288-300.
83. Munch C, Sedlmeier R, Meyer T, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004;63:724-6. (Pubitemid 39100836)
84. Munch C, Rosenbohm A, Sperfeld AD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005;58:777-80. (Pubitemid 41552554)
85. Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet 2009;41:163-5.
86. Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010;465:223-6.
87. Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010;68:857-64.
88. Ticozzi N, Tiloca C, Morelli C, et al. Genetics of familial amyotrophic lateral sclerosis. Arch Ital Biol 2011;149:65-82.
89. Chelly J, Tumer Z, Tonnesen T, et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 1993;3:14-19. (Pubitemid 23063282)
90. Mercer JF, Livingston J, Hall B, et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet 1993;3:20-5. (Pubitemid 23063283)
91. Vulpe C, Levinson B, Whitney S, et al. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 1993;3:7-13. (Pubitemid 23063281)
92. Kaler SG, Gallo LK, Proud VK, et al. Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet 1994;8:195-202. (Pubitemid 24308369)
93. Menkes JH, Alter M, Steigleder GK, et al. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962;29:764-79.
94. Kennerson ML, Nicholson GA, Kaler SG, et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet 2010;86:343-52.
95. Kaler SG. ATP7A-related copper transport diseases-emerging concepts and future trends. Nat Rev Neurol 2011;7:15-29.
96. Kaler SG, Holmes CS, Goldstein DS, et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 2008;358:605-14. (Pubitemid 351214287)
97. Kaler SG. Menkes disease mutations and response to early copper histidine treatment. Nat Genet 1996;13:21-2.
98. Kaler SG, Buist NR, Holmes CS, et al. Early copper therapy in classic Menkes disease patients with a novel splicing mutation. Ann Neurol 1995;38:921-8. (Pubitemid 26004598)
99. Sheela SR, Latha M, Liu P, et al. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations. Clin Genet 2005;68:278-83. (Pubitemid 41179556)
100. Tang J, Donsante A, Desai V, et al. Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R. Mol Genet Metab 2008;95:174-81.
101. Rabin BA, Griffin JW, Crain BJ, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 1999;122:1539-50. (Pubitemid 29374129)
102. Zhao ZH, Chen WZ, Wu ZY, et al. A novel mutation in the senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:118-22.
103. Moreira MC, Klur S, Watanabe M, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet 2004;36:225-7. (Pubitemid 38282744)
104. Hirano M, Quinzii CM, Mitsumoto H, et al. Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:223-7.
105. Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004;74:1128-35. (Pubitemid 38669312)
106. Suraweera A, Lim Y, Woods R, et al. Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum Mol Genet 2009;18:3384-96.
107. Eggert C, Chari A, Laggerbauer B, et al. Spinal muscular atrophy: the RNP connection. Trends Mol Med 2006;12:113-21.
108. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000;103:525-35.
109. Rock MJ, Prenen J, Funari VA, et al. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet 2008;40:999-1003.
110. Krakow D, Vriens J, Camacho N, et al. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet 2009;84:307-15.
111. Auer-Grumbach M, Olschewski A, Papic L, et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 2010;42:160-4.
112. Deng HX, Klein CJ, Yan J, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010;42:165-9.
113. Landoure G, Zdebik AA, Martinez TL, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 2010;42:170-4.
114. DeLong R, Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch Neurol 1992;49:905-8.
115. Isozumi K, DeLong R, Kaplan J, et al. Linkage of scapuloperoneal spinal muscular atrophy to chromosome 12q24.1-q24.31. Hum Mol Genet 1996;5:1377-82. (Pubitemid 26335859)
116. Dyck PJ, Litchy WJ, Minnerath S, et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35:608-15. (Pubitemid 24153845)
117. Donaghy M, Kennett R. Varying occurrence of vocal cord paralysis in a family with autosomal dominant hereditary motor and sensory neuropathy. J Neurol 1999;246:552-5. (Pubitemid 29376279)
118. McEntagart ME, Reid SL, Irrthum A, et al. Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23-q24. Ann Neurol 2005;57:293-7. (Pubitemid 40179869)
119. Santoro L, Manganelli F, Di Maio L, et al. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family. Neuromuscul Disord 2002;12:399-404. (Pubitemid 34327216)
120. Fleury P, Hageman G. A dominantly inherited lower motor neuron disorder presenting at birth with associated arthrogryposis. J Neurol Neurosurg Psychiatry 1985;48:1037-48. (Pubitemid 16235990)
121. van der Vleuten AJ, van Ravenswaaij-Arts CM, Frijns CJ, et al. Localisation of the gene for a dominant congenital spinal muscular atrophy predominantly affecting the lower limbs to chromosome 12q23-q24. Eur J Hum Genet 1998;6:376-82. (Pubitemid 28395800)
122. Tabuchi K, Suzuki M, Mizuno A, et al. Hearing impairment in TRPV4 knockout mice. Neurosci Lett 2005;382:304-8. (Pubitemid 40733641)
123. Gevaert T, Vriens J, Segal A, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 2007;117:3453-62. (Pubitemid 350097001)
124. Chen DH, Sul Y, Weiss M, et al. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. Neurology 2010;75:1968-75.
125. Klein CJ, Shi Y, Fecto F, et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology 2011;76:887-94.
126. Berciano J, Baets J, Gallardo E, et al. Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. J Neurol 2011;258:1413-21.
127. D'Hoedt D, Owsianik G, Prenen J, et al. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem 2008;283:6272-80.
128. Baets J, De Jonghe P. TRPV4 neuropathies: calcium channel inhibition as a therapeutic target? Neurology 2011;76:856-7.
129. Fecto F, Shi Y, Huda R, et al. Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. J Biol Chem 2011;286:17281-91.
130. Weedon MN, Hastings R, Caswell R, et al. Exome Sequencing Identifies a DYNC1H1 Mutation in a Large Pedigree with Dominant Axonal Charcot-Marie-Tooth Disease. Am J Hum Genet 2011;89:308-12.
131. Bilsland LG, Sahai E, Kelly G, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A 2010;107:20523-8.
132. Maystadt I, Rezsohazy R, Barkats M, et al. The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet 2007;81:67-76. (Pubitemid 47001157)
133. Maystadt I, Zarhrate M, Leclair-Richard D, et al. A gene for an autosomal recessive lower motor neuron disease with childhood onset maps to 1p36. Neurology 2006;67:120-4. (Pubitemid 44305474)
134. Nishimura AL, Mitne-Neto M, Silva HC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004;75:822-31. (Pubitemid 39390489)
135. Viollet L, Barois A, Rebeiz JG, et al. Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13. Ann Neurol 2002;51:585-92.
136. Vucic S, Cheah BC, Yiannikas C, et al. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 2011;122:1860-6.